September 1, 2022 BRIDGEWATER, N.J. — Vyluma has checked off an important step in its Phase III CHAMP (Childhood Atropine for Myopia...
July 8, 2022 ATLANTA — Findings from Visioneering Technologies Inc.’s (VTI) six-year myopia management clinical trial were published in the Clinical Ophthalmology journal. The study...
January 24, 2022 ATLANTA — Visioneering Technologies Inc. announced that it has begun its international clinical trial that is designed to test...
November 2, 2021 SAN RAMON, Calif. — At the 2021 American Academy of Optometry Meeting in Boston, CooperVision announced the results from...